Literature DB >> 19807733

Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.

Christopher Forbes1, Qicun Shi, Jed F Fisher, Mijoon Lee, Dusan Hesek, Leticia I Llarrull, Marta Toth, Michael Gossing, Rafael Fridman, Shahriar Mobashery.   

Abstract

(+/-)-2-[(4-Phenoxyphenylsulfonyl)methyl]thiirane 1 is a potent and selective mechanism-based inhibitor of the gelatinase sub-class of the zinc-dependent matrix metalloproteinase family. Inhibitor 1 has excellent activity in in vivo models of gelatinase-dependent disease. We demonstrate that the mechanism of inhibition is a rate-limiting gelatinase-catalyzed thiolate generation via deprotonation adjacent to the thiirane, with concomitant thiirane opening. A corollary to this mechanism is the prediction that thiol-containing structures, related to thiirane-opened 1, will possess potent matrix metalloproteinase inhibitory activity. This prediction was validated by the synthesis of the product of this enzyme-catalyzed reaction on 1, which exhibited a remarkable K(i) of 530 pm against matrix metalloproteinase-2. Thiirane 1 acts as a caged thiol, unmasked selectively in the active sites of gelatinases. This mechanism is unprecedented in the substantial literature on inhibition of zinc-dependent hydrolases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807733      PMCID: PMC2837476          DOI: 10.1111/j.1747-0285.2009.00881.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  43 in total

1.  Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.

Authors:  Gabriel Rosenblum; Philippe E Van den Steen; Sidney R Cohen; J Günter Grossmann; Jessica Frenkel; Rotem Sertchook; Nelle Slack; Richard W Strange; Ghislain Opdenakker; Irit Sagi
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

2.  Protease yoga: extreme flexibility of a matrix metalloproteinase.

Authors:  Christopher M Overall; Georgina S Butler
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

3.  Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma.

Authors:  Gabriel Rosenblum; Samy Meroueh; Marta Toth; Jed F Fisher; Rafael Fridman; Shahriar Mobashery; Irit Sagi
Journal:  J Am Chem Soc       Date:  2007-10-12       Impact factor: 15.419

4.  Computational investigation of irreversible inactivation of the zinc-dependent protease carboxypeptidase A.

Authors:  Jason B Cross; Thom Vreven; Samy O Meroueh; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Phys Chem B       Date:  2005-03-17       Impact factor: 2.991

5.  Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP.

Authors:  Argiris A Talamagas; Spiros Efthimiopoulos; Effie C Tsilibary; Maria E Figueiredo-Pereira; Athina K Tzinia
Journal:  Neurobiol Dis       Date:  2007-07-24       Impact factor: 5.996

6.  Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury.

Authors:  Fengshan Yu; Hiroshi Kamada; Kuniyasu Niizuma; Hidenori Endo; Pak H Chan
Journal:  J Neurotrauma       Date:  2008-03       Impact factor: 5.269

7.  Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain.

Authors:  Dae-Hee Kim; Christina Lilliehook; Breana Roides; Zhuoxun Chen; Mayland Chang; Shahriar Mobashery; Steven A Goldman
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

8.  Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction.

Authors:  Christoph Wiesner; R Daniel Bonfil; Zhong Dong; Hamilto Yamamoto; Sanaa M Nabha; Hong Meng; Allen Saliganan; Aaron Sabbota; Michael L Cher
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

9.  Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the regiospecificity and the inhibition potency of epoxide- and aziridine-based inhibitors.

Authors:  Milena Mladenovic; Konstantin Junold; Reinhold F Fink; Walter Thiel; Tanja Schirmeister; Bernd Engels
Journal:  J Phys Chem B       Date:  2008-04-08       Impact factor: 2.991

10.  MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells.

Authors:  K L Sodek; M J Ringuette; T J Brown
Journal:  Br J Cancer       Date:  2007-07-03       Impact factor: 7.640

View more
  23 in total

1.  QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

Authors:  Jia Zhou; Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Chem Theory Comput       Date:  2010-11-09       Impact factor: 6.006

2.  O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.

Authors:  Major Gooyit; Wei Song; Kiran V Mahasenan; Katerina Lichtenwalter; Mark A Suckow; Valerie A Schroeder; William R Wolter; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2013-10-08       Impact factor: 7.446

3.  Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier.

Authors:  Major Gooyit; Mark A Suckow; Valerie A Schroeder; William R Wolter; Shahriar Mobashery; Mayland Chang
Journal:  ACS Chem Neurosci       Date:  2012-07-30       Impact factor: 4.418

4.  Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors.

Authors:  Mijoon Lee; Masahiro Ikejiri; Dennis Klimpel; Marta Toth; Mana Espahbodi; Dusan Hesek; Christopher Forbes; Malika Kumarasiri; Bruce C Noll; Mayland Chang; Shahriar Mobashery
Journal:  ACS Med Chem Lett       Date:  2012-05-02       Impact factor: 4.345

5.  Exploitation of Conformational Dynamics in Imparting Selective Inhibition for Related Matrix Metalloproteinases.

Authors:  Kiran V Mahasenan; Maria Bastian; Ming Gao; Emma Frost; Derong Ding; Katerina Zorina-Lichtenwalter; John Jacobs; Mark A Suckow; Valerie A Schroeder; William R Wolter; Mayland Chang; Shahriar Mobashery
Journal:  ACS Med Chem Lett       Date:  2017-05-01       Impact factor: 4.345

6.  A chemical biological strategy to facilitate diabetic wound healing.

Authors:  Major Gooyit; Zhihong Peng; William R Wolter; Hualiang Pi; Derong Ding; Dusan Hesek; Mijoon Lee; Bill Boggess; Matthew M Champion; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  ACS Chem Biol       Date:  2013-09-26       Impact factor: 5.100

7.  Selective water-soluble gelatinase inhibitor prodrugs.

Authors:  Major Gooyit; Mijoon Lee; Valerie A Schroeder; Masahiro Ikejiri; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2011-09-06       Impact factor: 7.446

8.  Sulfonate-containing thiiranes as selective gelatinase inhibitors.

Authors:  Sebastian A Testero; Mijoon Lee; Rachel T Staran; Mana Espahbodi; Leticia I Llarrull; Marta Toth; Shahriar Mobashery; Mayland Chang
Journal:  ACS Med Chem Lett       Date:  2010-12-13       Impact factor: 4.345

9.  Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy.

Authors:  Ming Gao; Trung T Nguyen; Mark A Suckow; William R Wolter; Major Gooyit; Shahriar Mobashery; Mayland Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

10.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.